Tang K, Chen Y, Chen T, Chao Y, Kung S, Chen D
Mediators Inflamm. 2025; 2024:5568822.
PMID: 39742289
PMC: 11688129.
DOI: 10.1155/mi/5568822.
Li T, Guo S, Xu C, Zhang M, Lyu C, Xu H
J Immunother Cancer. 2024; 12(11).
PMID: 39581706
PMC: 11590841.
DOI: 10.1136/jitc-2024-010534.
Lim J, La J, Kim H, Kang I, Kang B, Ku K
iScience. 2024; 27(9):110810.
PMID: 39286510
PMC: 11404196.
DOI: 10.1016/j.isci.2024.110810.
Jacques C, Marchand F, Chatelais M, Albinet V, Coustal C, Floris I
Cancers (Basel). 2024; 16(7).
PMID: 38611099
PMC: 11010933.
DOI: 10.3390/cancers16071421.
Su C, Kim J, Tang J, Hung Y, Zuckermann F, Husmann R
PLoS Pathog. 2024; 20(3):e1012128.
PMID: 38547254
PMC: 11003694.
DOI: 10.1371/journal.ppat.1012128.
Nucleotide metabolism, leukodystrophies, and CNS pathology.
Gavazzi F, Gonzalez C, Arnold K, Swantkowski M, Charlton L, Modesti N
J Inherit Metab Dis. 2024; 47(5):860-875.
PMID: 38421058
PMC: 11358362.
DOI: 10.1002/jimd.12721.
Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage.
Tong A, Leylek R, Herzner A, Rigas D, Wichner S, Blanchette C
J Exp Med. 2023; 221(2).
PMID: 38095631
PMC: 10720541.
DOI: 10.1084/jem.20230341.
Sepsis leads to lasting changes in phenotype and function of naïve CD8 T cells.
Berton R, McGonagil P, Jensen I, Ybarra T, Bishop G, Harty J
PLoS Pathog. 2023; 19(10):e1011720.
PMID: 37824591
PMC: 10597476.
DOI: 10.1371/journal.ppat.1011720.
Phosphoflow cytometry to assess cytokine signaling pathways in peripheral immune cells: potential for inferring immune cell function and treatment response in patients with solid tumors.
Toney N, Schlom J, Donahue R
J Exp Clin Cancer Res. 2023; 42(1):247.
PMID: 37741983
PMC: 10517546.
DOI: 10.1186/s13046-023-02802-1.
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy.
Uccello T, Lesch M, Kintzel S, Gradzewicz L, Lamrous L, Murphy S
Cell Death Dis. 2023; 14(7):470.
PMID: 37495596
PMC: 10372053.
DOI: 10.1038/s41419-023-05999-3.
Type 1 interferon mediated signaling is indispensable for eliciting anti-tumor responses by .
Roy G, Chakraborty A, Swami B, Pal L, Ahuja C, Basak S
Front Immunol. 2023; 14:1104711.
PMID: 37122749
PMC: 10140407.
DOI: 10.3389/fimmu.2023.1104711.
Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice.
Wilken L, Stelz S, Prajeeth C, Rimmelzwaan G
Viruses. 2023; 15(4).
PMID: 37112795
PMC: 10142689.
DOI: 10.3390/v15040814.
New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy.
Gerber S, Uccello T, Lesch M, Kintzel S, Gradzewicz L, Lamrous L
Res Sq. 2023; .
PMID: 37090639
PMC: 10120761.
DOI: 10.21203/rs.3.rs-2767780/v1.
Ectopic expression of cGAS in enhances STING-mediated IFN-β response in human macrophages and dendritic cells.
Waanders L, van der Donk L, Ates L, Maaskant J, van Hamme J, Eldering E
J Immunother Cancer. 2023; 11(4).
PMID: 37072345
PMC: 10124277.
DOI: 10.1136/jitc-2022-005839.
A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer.
Ding N, You A, Yang H, Hu G, Lai C, Liu W
Clin Cancer Res. 2023; 29(11):2095-2109.
PMID: 36951687
PMC: 10233356.
DOI: 10.1158/1078-0432.CCR-22-3836.
Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets.
Bradford H, Haljasmagi L, Menon M, McDonnell T, Sarekannu K, Vanker M
Cell Rep Med. 2023; 4(1):100894.
PMID: 36652906
PMC: 9873953.
DOI: 10.1016/j.xcrm.2022.100894.
CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop.
Harrer D, Schenkel C, Bezler V, Kaljanac M, Hartley J, Barden M
Cells. 2022; 11(23).
PMID: 36497099
PMC: 9737386.
DOI: 10.3390/cells11233839.
Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex.
Korosec C, Farhang-Sardroodi S, Dick D, Gholami S, Ghaemi M, Moyles I
Sci Rep. 2022; 12(1):21232.
PMID: 36481777
PMC: 9732004.
DOI: 10.1038/s41598-022-25134-0.
Inflammatory Cytokines That Enhance Antigen Responsiveness of Naïve CD8 T Lymphocytes Modulate Chromatin Accessibility of Genes Impacted by Antigen Stimulation.
Quenum A, Santharam M, Ramanathan S, Ilangumaran S
Int J Mol Sci. 2022; 23(22).
PMID: 36430600
PMC: 9698886.
DOI: 10.3390/ijms232214122.
cART Restores Transient Responsiveness to IFN Type 1 in HIV-Infected Humanized Mice.
Gruenbach M, Muller C, Schlaepfer E, Baroncini L, Russenberger D, Kadzioch N
J Virol. 2022; 96(21):e0082722.
PMID: 36250708
PMC: 9645216.
DOI: 10.1128/jvi.00827-22.